ERBB2 and breast cancer: IFNγ secretion by NK cells has been shown to contribute to the tumor adaptive immune resistance response (154) by upregulating the expression of HLA-I and PD-L1 in HER2+ breast cancer cells in vitro and in vivo (58, 155, 156).